Literature DB >> 18251171

Complete remission of a case of hepatocellular carcinoma with tumor invasion in inferior vena cava and with pulmonary metastasis successfully treated with repeated arterial infusion chemotherapy.

Takayuki Kogure1, Takao Iwasaki, Yoshiyuki Ueno, Noriatsu Kanno, Koji Fukushima, Yoko Yamagiwa, Futoshi Nagasaki, Eiji Kakazu, Yasunori Matsuda, Osamu Kido, Yu Nakagome, Masashi Ninomiya, Tooru Shimosegawa.   

Abstract

We report the case of a patient having hepatocellular carcinoma with tumor invasion to the inferior vena cava and with multiple pulmonary metastases who was treated with repeated one-shot administration of epirubicin, cisplatin, and mitomycin C by hepatic artery and bronchial artery, which led to complete remission. A 72-year-old woman was diagnosed with infiltrative hepatocellular carcinoma with Vv3, multiple intrahepatic metastases, and multiple pulmonary metastases associated with compensated liver cirrhosis. One-shot infusion of epirubicin, cisplatin, and mitomycin C was performed through proper hepatic artery and bronchial artery for twice at eight weeks of intervals. Pulmonary metastases disappeared and intrahepatic lesions indicated marked shrinkage leaving a scar-like lesion with decreases in tumor markers. After six months and 20 months, tumor markers indicated increasing tendency but no evident recurrence was found by computed tomography or hepatic arteriography. One-shot infusion of the same regimens through proper hepatic artery was performed and tumor markers decreased to normal levels. After 14 months of the last therapy, no evidence of recurrence has been found on image analysis or in tumor markers. This arterial infusion therapy is well tolerated for the patients with compensated liver cirrhosis and might be promising for the effective treatment of advanced hepatocellular carcinoma with pulmonary metastases.

Entities:  

Mesh:

Year:  2007        PMID: 18251171

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

1.  Bortezomib induces tumor-specific cell death and growth inhibition in hepatocellular carcinoma and improves liver fibrosis.

Authors:  Issei Saeki; Shuji Terai; Koichi Fujisawa; Taro Takami; Naoki Yamamoto; Toshihiko Matsumoto; Yoshikazu Hirose; Yasuhiko Murata; Takahiro Yamasaki; Isao Sakaida
Journal:  J Gastroenterol       Date:  2012-09-26       Impact factor: 7.527

2.  A case of hepatocellular carcinoma with pulmonary metastases treated successfully with a combination of repeated hepatic arterial infusion epirubicin and Cisplatin chemotherapy and systemic low-dose infusion of 5-Fluorouracil.

Authors:  Yun-Jung Oh; Young-Min Park; Bo-Hyun Kim; Mi-Jin Kim; Jun-Hyung Cho; Chi-Woon Cha; Sang-Jong Park; Jae-Woo Yeon
Journal:  Gut Liver       Date:  2009-12-31       Impact factor: 4.519

3.  Pathological complete response by advanced hepatocellular carcinoma with massive macrovascular invasion to hepatic arterial infusion chemotherapy: a case report.

Authors:  Shusei Sano; Shinji Nakata; Shuichi Wada; Masatsugu Kuroiwa; Hiroki Sakai; Kei Kusama; Taiichi Machida; Akihito Nishio; Ichiro Ito; Harutsugu Sodeyama
Journal:  World J Surg Oncol       Date:  2019-12-26       Impact factor: 2.754

4.  Mitomycin C induces bystander killing in homogeneous and heterogeneous hepatoma cellular models.

Authors:  Ratna Kumari; Aanchal Sharma; Amrendra Kumar Ajay; Manoj Kumar Bhat
Journal:  Mol Cancer       Date:  2009-10-21       Impact factor: 27.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.